Regulatory News

Issue & allotment of Shares & Total Voting Rights

RNS Number : 2677U
Darktrace PLC
29 July 2022

29 July 2022

Darktrace plc



Issue and allotment of Shares under the Award Incentive Plan and Total Voting Rights

Darktrace announces the issue and allotment of shares pursuant to the vesting of awards granted under its Darktrace plc 2021 Award Incentive Plan to certain Darktrace employees. Darktrace has issued and allotted an aggregate of 8,977,642 new ordinary shares of £0.01 each in Darktrace (the "New Shares") to be delivered to the trustee of The Darktrace Employee Benefit Trust to satisfy the awards that are due to vest on 2 August 2022. An application has been made for the New Shares to be admitted to the Premium Listing Segment of the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange.

The New Shares will rank pari passu in all respects with Darktrace's existing ordinary shares of £0.01 nominal value each ("Ordinary Shares"). It is expected that admission will become effective on 2 August 2022.

As a result of the 8,977,642 New Shares issued, the total number of Ordinary Shares outstanding is 710,845,703. Each Ordinary Share carries the right to one vote. Darktrace has 2,034,684 Ordinary Shares as treasury shares with no voting rights. Therefore as at the close of business on 29 July 2022 the total voting rights figure of 708,811,019 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Darktrace under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.


Luk Janssens - Head of Investor Relations, Darktrace

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.